NICARDIPINE

NICARDIPINE was reported 4421 times

NICARDIPINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DELAYED ISCHAEMIC NEUROLOGICAL DEFICIT 5 0.2381
1 URETERIC COMPRESSION 15 0.1974
2 NEUTROPENIA NEONATAL 34 0.1518
3 ALCOHOLIC COMA 2 0.1176
4 ALEXITHYMIA 5 0.1000
5 SUPERIMPOSED PRE-ECLAMPSIA 3 0.0857
6 MYOCARDIAL CALCIFICATION 9 0.0769
7 GASTRIC ILEUS 4 0.0702
8 HAEMORRHAGIC TUMOUR NECROSIS 3 0.0638
9 FOETAL DISORDER 53 0.0634
10 BLOOD LACTIC ACID 8 0.0620
11 CRANIOPLASTY 3 0.0600
12 BURKHOLDERIA TEST POSITIVE 7 0.0565
13 PHLEBITIS DEEP 4 0.0541
14 CEREBRAL VASOCONSTRICTION 37 0.0501
15 HYPERPLASIA ADRENAL 3 0.0476
16 NOREPINEPHRINE INCREASED 5 0.0382
17 RENAL FAILURE NEONATAL 8 0.0360
18 XANTHELASMA 4 0.0348
19 KIDNEY SMALL 10 0.0341
20 HEPARIN RESISTANCE 4 0.0328
21 HYPERTENSION NEONATAL 3 0.0309
22 HEMIVERTEBRA 5 0.0296
23 TERM BIRTH 4 0.0290
24 WRONG PATIENT 14 0.0279
25 SICCA SYNDROME 5 0.0259
26 DIABETIC KETOSIS 8 0.0211
27 UMBILICAL CORD VASCULAR DISORDER 3 0.0208
28 FOETAL HEART RATE DISORDER 4 0.0207
29 LEFT-TO-RIGHT CARDIAC SHUNT 6 0.0203
30 PHAEOCHROMOCYTOMA CRISIS 4 0.0189
31 FOETAL ARRHYTHMIA 5 0.0186
32 PORPHYRIA 7 0.0182
33 PLATELET DYSFUNCTION 5 0.0180
34 PUTAMEN HAEMORRHAGE 5 0.0175
35 CONGENITAL CHOROID PLEXUS CYST 5 0.0164
36 CEREBRAL VENTRICULAR RUPTURE 3 0.0164
37 NEUROMUSCULAR BLOCK PROLONGED 6 0.0163
38 RESPIRATORY GAS EXCHANGE DISORDER 6 0.0162
39 HAEMORRHAGIC TRANSFORMATION STROKE 24 0.0159
40 VENTRICULAR TACHYARRHYTHMIA 5 0.0157
41 HAEMORRHAGIC CEREBRAL INFARCTION 11 0.0157
42 PYELOCALIECTASIS 15 0.0157
43 NEONATAL RESPIRATORY DISTRESS 14 0.0148
44 ANAEMIA NEONATAL 7 0.0145
45 LABILE HYPERTENSION 4 0.0145
46 PULMONARY HYPOPLASIA 11 0.0140
47 LEFT VENTRICULAR END-DIASTOLIC PRESSURE INCREASED 3 0.0139
48 ENTEROBACTER SEPSIS 5 0.0135
49 DEVICE COMPUTER ISSUE 4 0.0134
50 HAEMATOMA MUSCLE 16 0.0133
51 STAPHYLOCOCCAL SCALDED SKIN SYNDROME 3 0.0133
52 MACROGLOSSIA 7 0.0127
53 VIRAL HAEMORRHAGIC CYSTITIS 9 0.0126
54 LOW BIRTH WEIGHT BABY 99 0.0124
55 FOETAL DISTRESS SYNDROME 26 0.0122
56 CLINODACTYLY 3 0.0109
57 NEONATAL HYPOTENSION 4 0.0109
58 TUMOUR RUPTURE 6 0.0107
59 ATRIOVENTRICULAR SEPTAL DEFECT 5 0.0106
60 THALAMUS HAEMORRHAGE 9 0.0103
61 TRANSIENT TACHYPNOEA OF THE NEWBORN 4 0.0101
62 MITRAL VALVE THICKENING 3 0.0101
63 HYPERLACTACIDAEMIA 27 0.0101
64 BRONCHOPULMONARY DYSPLASIA 8 0.0099
65 RETINOPATHY HYPERTENSIVE 3 0.0099
66 HELLP SYNDROME 6 0.0098
67 LOW SET EARS 4 0.0097
68 HYPERTENSIVE EMERGENCY 11 0.0093
69 HYPERMAGNESAEMIA 6 0.0092
70 MATERNAL EXPOSURE DURING DELIVERY 9 0.0091
71 ACUTE PULMONARY OEDEMA 50 0.0089
72 INTRACRANIAL HAEMATOMA 5 0.0089
73 ACUTE MOTOR-SENSORY AXONAL NEUROPATHY 2 0.0087
74 APGAR SCORE LOW 11 0.0085
75 DELAYED RECOVERY FROM ANAESTHESIA 8 0.0084
76 CEREBRAL MASS EFFECT 3 0.0083
77 WEANING FAILURE 3 0.0082
78 SCLERODERMA RENAL CRISIS 3 0.0079
79 FOETAL GROWTH RESTRICTION 47 0.0077
80 MYOGLOBINURIA 4 0.0075
81 NECROTISING ENTEROCOLITIS NEONATAL 3 0.0074
82 CRYSTALLURIA 4 0.0074
83 RENAL ISCHAEMIA 4 0.0073
84 VASCULAR STENT STENOSIS 3 0.0071
85 FOETAL HEART RATE DECELERATION ABNORMALITY 5 0.0071
86 GESTATIONAL HYPERTENSION 9 0.0070
87 PREMATURE BABY 209 0.0069
88 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 11 0.0069
89 PREMATURE DELIVERY 109 0.0068
90 NEONATAL RESPIRATORY DISTRESS SYNDROME 24 0.0068
91 HYPERTHERMIA MALIGNANT 10 0.0067
92 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 62 0.0065
93 STATUS ASTHMATICUS 3 0.0064
94 INTRACRANIAL MASS 6 0.0063
95 PRE-ECLAMPSIA 30 0.0063
96 CEREBRAL ARTERY STENOSIS 3 0.0061
97 LEUKOCYTURIA 5 0.0061
98 EMBOLIC CEREBRAL INFARCTION 4 0.0060
99 HEPATIC CYTOLYSIS 76 0.0060
100 THROMBOCYTOPENIC PURPURA 8 0.0058
101 MALIGNANT HYPERTENSION 5 0.0058
102 DIABETIC METABOLIC DECOMPENSATION 8 0.0058
103 NEONATAL ASPHYXIA 4 0.0056
104 DYSLALIA 4 0.0055
105 THROMBOCYTHAEMIA 3 0.0054
106 BRAIN HERNIATION 16 0.0054
107 FEBRILE BONE MARROW APLASIA 22 0.0052
108 HYPERTROPHIC CARDIOMYOPATHY 8 0.0052
109 HYPOTONIA NEONATAL 8 0.0051
110 ENDOTRACHEAL INTUBATION COMPLICATION 3 0.0051
111 ACQUIRED HAEMOPHILIA 5 0.0050
112 PORPHYRIA ACUTE 7 0.0049
113 VASOPLEGIA SYNDROME 8 0.0049
114 PREMATURE LABOUR 27 0.0048
115 JAUNDICE NEONATAL 9 0.0048
116 MITRAL VALVE CALCIFICATION 3 0.0047
117 POST-INJECTION DELIRIUM SEDATION SYNDROME 4 0.0046
118 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 36 0.0046
119 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 9 0.0046
120 PHAEOCHROMOCYTOMA 3 0.0046
121 EMBOLIC STROKE 16 0.0045
122 POSTPARTUM HAEMORRHAGE 6 0.0045
123 INTRAVENTRICULAR HAEMORRHAGE 11 0.0044
124 INTESTINAL INFARCTION 4 0.0044
125 SYSTEMIC CANDIDA 11 0.0044
126 INTRA-UTERINE DEATH 7 0.0044
127 RENAL ARTERY STENOSIS 6 0.0044
128 CEREBRAL VENTRICLE DILATATION 5 0.0043
129 BRAIN STEM HAEMORRHAGE 4 0.0042
130 EOSINOPHILIA 74 0.0042
131 ANURIA 36 0.0042
132 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 3 0.0042
133 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 5 0.0042
134 RED BLOOD CELLS URINE POSITIVE 4 0.0041
135 AREFLEXIA 11 0.0041
136 AMNESTIC DISORDER 2 0.0041
137 CEREBRAL ARTERY EMBOLISM 5 0.0041
138 CLONIC CONVULSION 3 0.0041
139 AORTIC VALVE SCLEROSIS 3 0.0041
140 OLIGOHYDRAMNIOS 13 0.0039
141 ANAPHYLACTOID REACTION 16 0.0039
142 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 3 0.0038
143 FOETAL GROWTH RETARDATION 3 0.0038
144 PRODUCT INEFFECTIVE 3 0.0038
145 ENDOCARDITIS BACTERIAL 3 0.0038
146 SPUTUM CULTURE POSITIVE 3 0.0037
147 RASH MACULO-PAPULAR 82 0.0037
148 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 12 0.0036
149 BRADYCARDIA FOETAL 3 0.0036
150 SEPTIC EMBOLUS 3 0.0036
151 RASH MORBILLIFORM 10 0.0036
152 LINEAR IGA DISEASE 6 0.0036
153 ATRIOVENTRICULAR BLOCK COMPLETE 24 0.0036
154 PNEUMONIA STAPHYLOCOCCAL 7 0.0035
155 LICHENOID KERATOSIS 8 0.0035
156 CEREBELLAR HAEMORRHAGE 5 0.0035
157 FIXED ERUPTION 6 0.0035
158 NECROTISING MYOSITIS 3 0.0035
159 RASH PUSTULAR 25 0.0034
160 HYPERLEUKOCYTOSIS 3 0.0034
161 AORTIC DISSECTION 14 0.0034
162 HYPOSPADIAS 7 0.0034
163 INTRA-ABDOMINAL FLUID COLLECTION 6 0.0033
164 CANDIDA SEPSIS 3 0.0033
165 MIXED LIVER INJURY 10 0.0033
166 POTENTIATING DRUG INTERACTION 11 0.0033
167 CAESAREAN SECTION 38 0.0033
168 CYTOMEGALOVIRUS VIRAEMIA 14 0.0031
169 EPIDERMAL NECROSIS 3 0.0031
170 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 8 0.0031
171 PATENT DUCTUS ARTERIOSUS 12 0.0030
172 ADMINISTRATION SITE EXTRAVASATION 3 0.0030
173 METABOLIC ENCEPHALOPATHY 9 0.0030
174 THROMBOTIC MICROANGIOPATHY 29 0.0030
175 ILEAL ULCER 3 0.0030
176 HYPERTENSIVE CRISIS 33 0.0030
177 OFF LABEL USE OF DEVICE 4 0.0030
178 INJECTION SITE OEDEMA 5 0.0029
179 LEFT VENTRICULAR FAILURE 10 0.0029
180 NON-ALCOHOLIC STEATOHEPATITIS 3 0.0029
181 ELECTROENCEPHALOGRAM ABNORMAL 9 0.0028
182 ENTEROCOCCAL BACTERAEMIA 3 0.0028
183 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 3 0.0028
184 POLYOMAVIRUS VIRAEMIA 3 0.0028
185 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 6 0.0028
186 HYPERTENSIVE NEPHROPATHY 3 0.0028
187 NEPHROGENIC ANAEMIA 13 0.0028
188 CYTOMEGALOVIRUS TEST POSITIVE 5 0.0028
189 HAEMOLYTIC ANAEMIA 25 0.0028
190 SUBARACHNOID HAEMORRHAGE 28 0.0027
191 ACCOMMODATION DISORDER 2 0.0027
192 OLIGURIA 17 0.0027
193 WRONG PATIENT RECEIVED PRODUCT 8 0.0027
194 CEREBRAL HAEMATOMA 9 0.0027
195 INTERVERTEBRAL DISCITIS 5 0.0026
196 KOUNIS SYNDROME 6 0.0026
197 GINGIVAL HYPERTROPHY 4 0.0026
198 ACUTE PRERENAL FAILURE 3 0.0026
199 ISCHAEMIC CEREBRAL INFARCTION 3 0.0026
200 ESCHERICHIA BACTERAEMIA 6 0.0025
201 CARDIAC FAILURE ACUTE 17 0.0025
202 RESPIRATORY ACIDOSIS 10 0.0025
203 PHLEBITIS 13 0.0025
204 PRODUCT CONTAMINATION MICROBIAL 3 0.0025
205 EMBOLISM ARTERIAL 3 0.0025
206 HAEMODYNAMIC INSTABILITY 19 0.0025
207 ILEUS PARALYTIC 11 0.0025
208 PARADOXICAL DRUG REACTION 9 0.0024
209 FOETAL EXPOSURE DURING PREGNANCY 198 0.0024
210 EXTRAVASATION 10 0.0024
211 INTRA-ABDOMINAL HAEMATOMA 3 0.0024
212 CEREBRAL INFARCTION 59 0.0024
213 HYDROCEPHALUS 13 0.0024
214 GAZE PALSY 4 0.0023
215 HYPERCAPNIA 7 0.0023
216 PNEUMONIA ASPIRATION 58 0.0023
217 PARTIAL SEIZURES 12 0.0023
218 HEMIPLEGIA 19 0.0023
219 HYPERKALAEMIA 80 0.0023
220 GRAFT VERSUS HOST DISEASE IN SKIN 5 0.0023
221 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 4 0.0023
222 JUGULAR VEIN THROMBOSIS 4 0.0022
223 COMPLICATIONS OF TRANSPLANTED KIDNEY 5 0.0022
224 HYPERAMMONAEMIA 11 0.0022
225 ISCHAEMIC HEPATITIS 3 0.0022
226 ACUTE GRAFT VERSUS HOST DISEASE 10 0.0022
227 PNEUMONIA KLEBSIELLA 4 0.0022
228 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 6 0.0022
229 DEATH NEONATAL 3 0.0022
230 VASCULAR PURPURA 3 0.0021
231 CHOLESTASIS 41 0.0021
232 ASPERGILLUS INFECTION 14 0.0021
233 PRERENAL FAILURE 3 0.0021
234 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 3 0.0021
235 POISONING DELIBERATE 20 0.0021
236 CYTOLYTIC HEPATITIS 7 0.0021
237 CARDIAC TAMPONADE 10 0.0021
238 TRACHEOSTOMY 3 0.0021
239 INTRA-ABDOMINAL HAEMORRHAGE 5 0.0021
240 MATERNAL EXPOSURE DURING PREGNANCY 187 0.0021
241 CEREBRAL HAEMORRHAGE 75 0.0021
242 BK VIRUS INFECTION 7 0.0021
243 RENAL INFARCT 3 0.0021
244 TRAUMATIC LUNG INJURY 4 0.0021
245 NODAL RHYTHM 3 0.0020
246 PSYCHIATRIC DECOMPENSATION 4 0.0020
247 OCCULT BLOOD POSITIVE 4 0.0020
248 CELL DEATH 4 0.0020
249 VENOOCCLUSIVE DISEASE 5 0.0020
250 HYPERPARATHYROIDISM SECONDARY 5 0.0020
251 ARTERIOSPASM CORONARY 8 0.0020
252 HEART DISEASE CONGENITAL 7 0.0020
253 ANGLE CLOSURE GLAUCOMA 5 0.0020
254 HYPERURICAEMIA 8 0.0019
255 CONCOMITANT DISEASE AGGRAVATED 12 0.0019
256 CHOLECYSTITIS ACUTE 11 0.0019
257 CHRONIC GRAFT VERSUS HOST DISEASE 7 0.0019
258 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 5 0.0019
259 AKINESIA 4 0.0019
260 SINUS ARREST 3 0.0019
261 HALLUCINATIONS, MIXED 8 0.0019
262 TOXIC SKIN ERUPTION 19 0.0019
263 ORTHOPNOEA 6 0.0019
264 METABOLIC ALKALOSIS 3 0.0019
265 LEFT VENTRICULAR HYPERTROPHY 8 0.0019
266 HYPONATRAEMIA 105 0.0019
267 HYPOGLYCAEMIA NEONATAL 3 0.0019
268 LIVER ABSCESS 6 0.0018
269 CARDIOVASCULAR INSUFFICIENCY 3 0.0018
270 HYPOVENTILATION 6 0.0018
271 SUBDURAL HAEMORRHAGE 5 0.0018
272 BRADYARRHYTHMIA 3 0.0018
273 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 4 0.0018
274 INTESTINAL ISCHAEMIA 10 0.0018
275 DRUG LEVEL BELOW THERAPEUTIC 10 0.0018
276 BLOOD PRESSURE SYSTOLIC DECREASED 8 0.0018
277 ACUTE RESPIRATORY DISTRESS SYNDROME 31 0.0018
278 DRUG LEVEL ABOVE THERAPEUTIC 8 0.0017
279 NEUROLOGICAL DECOMPENSATION 4 0.0017
280 HAEMOLYTIC URAEMIC SYNDROME 4 0.0017
281 VASCULAR PSEUDOANEURYSM 3 0.0017
282 GASTROINTESTINAL NECROSIS 5 0.0017
283 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 44 0.0017
284 DYSMORPHISM 4 0.0017
285 BRADYCARDIA 90 0.0017
286 HEPATOCELLULAR INJURY 24 0.0017
287 EXPOSURE DURING PREGNANCY 104 0.0017
288 PREMATURE RUPTURE OF MEMBRANES 4 0.0017
289 CEREBRAL VENOUS THROMBOSIS 3 0.0017
290 ACUTE KIDNEY INJURY 252 0.0016
291 CAROTID ARTERY OCCLUSION 6 0.0016
292 CONDUCTION DISORDER 3 0.0016
293 RESPIRATORY DISTRESS 45 0.0016
294 AMYLASE INCREASED 6 0.0016
295 HEPARIN-INDUCED THROMBOCYTOPENIA 8 0.0016
296 PUPILLARY REFLEX IMPAIRED 3 0.0016
297 HYPERVOLAEMIA 8 0.0016
298 HYPOXIA 57 0.0016
299 EOSINOPHILIC PNEUMONIA 5 0.0016
300 CIRCULATORY COLLAPSE 27 0.0016
301 PURPURA 14 0.0016
302 HYPOPROTEINAEMIA 3 0.0016
303 TOXIC EPIDERMAL NECROLYSIS 24 0.0016
304 VENTRICULAR SEPTAL DEFECT 9 0.0016
305 PANCREATIC CYST 3 0.0016
306 HYPOKALAEMIA 72 0.0016
307 DRUG EXPOSURE DURING PREGNANCY 53 0.0016
308 CONGENITAL ANOMALY 12 0.0015
309 HYPOALBUMINAEMIA 12 0.0015
310 FOETAL DEATH 8 0.0015
311 DERMATITIS BULLOUS 11 0.0015
312 CEREBRAL ATROPHY 6 0.0015
313 BRAIN OEDEMA 19 0.0015
314 CREATININE RENAL CLEARANCE DECREASED 6 0.0015
315 ALCOHOL POISONING 4 0.0015
316 SHOCK 34 0.0015
317 COLITIS MICROSCOPIC 7 0.0015
318 NORMAL NEWBORN 8 0.0015
319 HAEMATOMA 38 0.0015
320 ORAL FUNGAL INFECTION 4 0.0015
321 TYPE IV HYPERSENSITIVITY REACTION 4 0.0015
322 RED BLOOD CELL COUNT INCREASED 4 0.0014
323 DRUG LEVEL INCREASED 24 0.0014
324 ACUTE CORONARY SYNDROME 12 0.0014
325 DERMATITIS EXFOLIATIVE GENERALISED 5 0.0014
326 PETECHIAE 15 0.0014
327 LUNG CONSOLIDATION 4 0.0014
328 DILATATION VENTRICULAR 3 0.0014
329 STAPHYLOCOCCAL SEPSIS 7 0.0014
330 FIBRIN D DIMER INCREASED 5 0.0014
331 ENTERITIS 9 0.0014
332 ANAEMIA MACROCYTIC 3 0.0014
333 HAEMORRHAGE INTRACRANIAL 21 0.0014
334 SPEECH DISORDER DEVELOPMENTAL 4 0.0014
335 CARDIOGENIC SHOCK 20 0.0014
336 PARAPLEGIA 4 0.0014
337 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 7 0.0014
338 ADENOVIRUS INFECTION 4 0.0014
339 CUTANEOUS VASCULITIS 5 0.0014
340 AUTONOMIC NERVOUS SYSTEM IMBALANCE 4 0.0014
341 NEUTROPHIL COUNT INCREASED 14 0.0014
342 HEPATITIS FULMINANT 4 0.0013
343 HISTIOCYTOSIS HAEMATOPHAGIC 4 0.0013
344 LEUKOENCEPHALOPATHY 5 0.0013
345 MULTIPLE ORGAN DYSFUNCTION SYNDROME 38 0.0013
346 RETINOPATHY 5 0.0013
347 ALTERED STATE OF CONSCIOUSNESS 29 0.0013
348 BLOOD CULTURE POSITIVE 4 0.0013
349 BLOOD PRESSURE INADEQUATELY CONTROLLED 8 0.0013
350 VARICES OESOPHAGEAL 4 0.0013
351 CONJUNCTIVAL HAEMORRHAGE 5 0.0013
352 ISCHAEMIC STROKE 23 0.0013
353 BILIRUBIN CONJUGATED INCREASED 3 0.0013
354 HAEMORRHAGIC STROKE 10 0.0013
355 MULTI-ORGAN FAILURE 22 0.0013
356 PNEUMOTHORAX 20 0.0013
357 HEPATIC FUNCTION ABNORMAL 47 0.0013
358 LACUNAR INFARCTION 3 0.0013
359 GRAFT VERSUS HOST DISEASE 9 0.0013
360 METABOLIC ACIDOSIS 40 0.0012
361 KIDNEY TRANSPLANT REJECTION 6 0.0012
362 STUPOR 4 0.0012
363 SKIN EROSION 4 0.0012
364 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0012
365 HEPATITIS ACUTE 8 0.0012
366 SUDDEN DEATH 13 0.0012
367 BACTERIAL SEPSIS 4 0.0012
368 GAMMA-GLUTAMYLTRANSFERASE INCREASED 27 0.0012
369 CARDIAC ARREST 100 0.0012
370 PROTEINURIA 23 0.0012
371 RALES 7 0.0012
372 PROTEIN URINE PRESENT 6 0.0012
373 HYPOTONIA 12 0.0012
374 CORONARY ARTERY STENOSIS 6 0.0012
375 BRAIN ABSCESS 3 0.0012
376 TOXIC ENCEPHALOPATHY 6 0.0012
377 WRONG PRODUCT ADMINISTERED 8 0.0012
378 TROPONIN INCREASED 9 0.0012
379 ENCEPHALOPATHY 29 0.0012
380 AUTOIMMUNE HAEMOLYTIC ANAEMIA 4 0.0012
381 BRONCHOPULMONARY ASPERGILLOSIS 9 0.0012
382 ATRIOVENTRICULAR BLOCK FIRST DEGREE 5 0.0012
383 STAPHYLOCOCCAL BACTERAEMIA 5 0.0011
384 ORTHOSTATIC HYPOTENSION 20 0.0011
385 CATATONIA 6 0.0011
386 RADICULOPATHY 3 0.0011
387 DISSEMINATED INTRAVASCULAR COAGULATION 16 0.0011
388 BLOOD UREA INCREASED 19 0.0011
389 BLOOD ALBUMIN DECREASED 9 0.0011
390 AGRANULOCYTOSIS 21 0.0011
391 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
392 HYPERGLYCAEMIA 41 0.0011
393 ANAPHYLACTIC SHOCK 29 0.0011
394 HAEMORRHAGIC DIATHESIS 4 0.0011
395 RENAL TUBULAR NECROSIS 11 0.0011
396 SHOCK HAEMORRHAGIC 9 0.0011
397 IMMUNE THROMBOCYTOPENIA 5 0.0011
398 THROMBOCYTOSIS 4 0.0011
399 VENTRICULAR TACHYCARDIA 18 0.0011
400 PNEUMONIA BACTERIAL 10 0.0011
401 ISCHAEMIA 5 0.0011
402 STATUS EPILEPTICUS 12 0.0011
403 ABORTION INDUCED 10 0.0011
404 HEPATIC NECROSIS 4 0.0011
405 MITRAL VALVE INCOMPETENCE 12 0.0011
406 RHABDOMYOLYSIS 44 0.0011
407 DRUG INTERACTION 167 0.0011
408 END STAGE RENAL DISEASE 19 0.0010
409 HAEMOLYSIS 8 0.0010
410 SINUS BRADYCARDIA 10 0.0010
411 TORSADE DE POINTES 8 0.0010
412 GROWTH RETARDATION 3 0.0010
413 LACTIC ACIDOSIS 33 0.0010
414 LYMPHOCYTE COUNT DECREASED 18 0.0010
415 VENOOCCLUSIVE LIVER DISEASE 5 0.0010
416 CREPITATIONS 3 0.0010
417 AZOTAEMIA 4 0.0010
418 RESPIRATORY FAILURE 73 0.0010
419 DERMATITIS EXFOLIATIVE 5 0.0010
420 HEPATITIS CHOLESTATIC 6 0.0010
421 ANGIOEDEMA 44 0.0010
422 BLOOD PRESSURE DECREASED 66 0.0010
423 CYSTITIS HAEMORRHAGIC 4 0.0010
424 PERIPHERAL ISCHAEMIA 4 0.0010
425 PANCREATITIS ACUTE 22 0.0010
426 SUBDURAL HAEMATOMA 14 0.0010
427 GOITRE 4 0.0010
428 BRAIN NATRIURETIC PEPTIDE INCREASED 3 0.0010
429 CEREBRAL ISCHAEMIA 5 0.0010
430 BRAIN DEATH 3 0.0010
431 PULMONARY OEDEMA 43 0.0010
432 PULSELESS ELECTRICAL ACTIVITY 4 0.0010
433 LIVE BIRTH 8 0.0010
434 ATRIAL SEPTAL DEFECT 8 0.0010
435 SERUM FERRITIN INCREASED 5 0.0009
436 PRODUCT ADMINISTRATION ERROR 19 0.0009
437 CARDIAC FAILURE CHRONIC 4 0.0009
438 ACUTE RESPIRATORY FAILURE 18 0.0009
439 PSEUDOMONAS INFECTION 8 0.0009
440 EPILEPSY 28 0.0009
441 ADRENAL INSUFFICIENCY 11 0.0009
442 DRUG ERUPTION 16 0.0009
443 CYTOMEGALOVIRUS INFECTION 15 0.0009
444 GASTRIC ULCER HAEMORRHAGE 5 0.0009
445 NECROSIS 5 0.0009
446 HYPOCALCAEMIA 17 0.0009
447 PNEUMOCYSTIS JIROVECII PNEUMONIA 9 0.0009
448 SEPTIC SHOCK 39 0.0009
449 MALNUTRITION 10 0.0009
450 GENERALISED OEDEMA 11 0.0009
451 POSTOPERATIVE WOUND INFECTION 6 0.0009
452 CLOSTRIDIAL INFECTION 3 0.0009
453 SUSPECTED OFF LABEL USE 4 0.0009
454 REBOUND EFFECT 10 0.0009
455 DEPRESSED LEVEL OF CONSCIOUSNESS 35 0.0009
456 BLOOD LACTATE DEHYDROGENASE INCREASED 14 0.0009
457 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 9 0.0009
458 HYPOTENSION 175 0.0009
459 HYPERBILIRUBINAEMIA 9 0.0009
460 ENCEPHALITIS 6 0.0009
461 UROSEPSIS 8 0.0009
462 HYPOMAGNESAEMIA 12 0.0009
463 STRESS CARDIOMYOPATHY 5 0.0009
464 BACTERIAL INFECTION 16 0.0009
465 HYPERTRIGLYCERIDAEMIA 5 0.0009
466 TUBULOINTERSTITIAL NEPHRITIS 16 0.0009
467 BACTERAEMIA 10 0.0008
468 PANCYTOPENIA 47 0.0008
469 ACUTE MYELOID LEUKAEMIA 13 0.0008
470 RASH VESICULAR 4 0.0008
471 INJECTION SITE VESICLES 5 0.0008
472 BLOOD PHOSPHORUS DECREASED 3 0.0008
473 HEPATITIS 21 0.0008
474 INCORRECT DOSAGE ADMINISTERED 4 0.0008
475 HYPOPHOSPHATAEMIA 6 0.0008
476 URINARY RETENTION 27 0.0008
477 INFUSION SITE EXTRAVASATION 5 0.0008
478 URINE OUTPUT DECREASED 7 0.0008
479 MATERNAL EXPOSURE TIMING UNSPECIFIED 3 0.0008
480 RENAL IMPAIRMENT 67 0.0008
481 PROTEIN TOTAL DECREASED 3 0.0008
482 HYPOTHERMIA 8 0.0008
483 HYPERTENSION 167 0.0008
484 DYSLIPIDAEMIA 4 0.0008
485 TONGUE OEDEMA 3 0.0008
486 DRUG LEVEL DECREASED 8 0.0008
487 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
488 ABDOMINAL INFECTION 2 0.0008
489 MATERNAL DRUGS AFFECTING FOETUS 6 0.0008
490 ENDOCARDITIS 4 0.0008
491 PERICARDIAL EFFUSION 18 0.0008
492 ATRIOVENTRICULAR BLOCK 6 0.0008
493 RENAL FAILURE 103 0.0008
494 OPTIC ISCHAEMIC NEUROPATHY 3 0.0008
495 APLASTIC ANAEMIA 4 0.0008
496 APHASIA 23 0.0008
497 PNEUMONIA FUNGAL 3 0.0008
498 IRON DEFICIENCY ANAEMIA 7 0.0008
499 RENAL FAILURE ACUTE 32 0.0008
500 ASPARTATE AMINOTRANSFERASE INCREASED 40 0.0008
501 BLOOD CREATININE INCREASED 49 0.0007
502 PREGNANCY 15 0.0007
503 TRANSPLANT REJECTION 6 0.0007
504 CYTOKINE RELEASE SYNDROME 15 0.0007
505 COMPRESSION FRACTURE 4 0.0007
506 GINGIVITIS 4 0.0007
507 COMA 35 0.0007
508 LUNG DISORDER 36 0.0007
509 POST PROCEDURAL COMPLICATION 14 0.0007
510 ATELECTASIS 7 0.0007
511 PLEURAL EFFUSION 44 0.0007
512 DELIRIUM 25 0.0007
513 ANGIOPATHY 4 0.0007
514 NEPHROPATHY TOXIC 8 0.0007
515 UTERINE HAEMORRHAGE 3 0.0007
516 GENERALISED ERYTHEMA 4 0.0007
517 ALANINE AMINOTRANSFERASE INCREASED 43 0.0007
518 NEUROLOGICAL SYMPTOM 4 0.0007
519 ENTEROCOLITIS 4 0.0007
520 MOTOR DYSFUNCTION 7 0.0007
521 PARONYCHIA 3 0.0007
522 PULMONARY CONGESTION 9 0.0007
523 ORAL DISORDER 5 0.0007
524 ASCITES 20 0.0007
525 LUNG INFILTRATION 6 0.0007
526 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 6 0.0007
527 STEVENS-JOHNSON SYNDROME 15 0.0007
528 NEUROLEPTIC MALIGNANT SYNDROME 8 0.0007
529 CARDIO-RESPIRATORY ARREST 28 0.0007
530 JAUNDICE 18 0.0007
531 BLOOD PRESSURE SYSTOLIC INCREASED 13 0.0007
532 INCONTINENCE 7 0.0007
533 LOW DENSITY LIPOPROTEIN INCREASED 5 0.0006
534 ERYTHEMA MULTIFORME 6 0.0006
535 OESOPHAGITIS 7 0.0006
536 YELLOW SKIN 3 0.0006
537 LYMPHOPENIA 9 0.0006
538 SINUS TACHYCARDIA 9 0.0006
539 PULSE ABSENT 3 0.0006
540 WHITE BLOOD CELL COUNT INCREASED 24 0.0006
541 PROCTALGIA 4 0.0006
542 CHOKING 12 0.0006
543 MENTAL STATUS CHANGES 17 0.0006
544 BREATH SOUNDS ABNORMAL 3 0.0006
545 SEPSIS 67 0.0006
546 CARDIAC FAILURE 48 0.0006
547 KLEBSIELLA INFECTION 3 0.0006
548 COLITIS ISCHAEMIC 4 0.0006
549 THROMBOCYTOPENIA 66 0.0006
550 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 10 0.0006
551 TUMOUR LYSIS SYNDROME 5 0.0006
552 CLOSTRIDIUM DIFFICILE COLITIS 6 0.0006
553 DIALYSIS 8 0.0006
554 ANAEMIA 107 0.0006
555 NEUTROPENIC SEPSIS 4 0.0006
556 PARALYSIS 8 0.0006
557 MYOSITIS 5 0.0006
558 BEHAVIOUR DISORDER 3 0.0006
559 HIP SURGERY 3 0.0006
560 SKIN LACERATION 6 0.0006
561 OPTIC NEURITIS 5 0.0005
562 FAECALOMA 3 0.0005
563 MOUTH HAEMORRHAGE 4 0.0005
564 ACUTE MYOCARDIAL INFARCTION 16 0.0005
565 UNRESPONSIVE TO STIMULI 14 0.0005
566 GRAND MAL CONVULSION 5 0.0005
567 LOWER GASTROINTESTINAL HAEMORRHAGE 4 0.0005
568 VENTRICULAR FIBRILLATION 6 0.0005
569 COAGULOPATHY 9 0.0005
570 INTRACRANIAL PRESSURE INCREASED 3 0.0005
571 RESPIRATORY DISORDER 16 0.0005
572 OEDEMA 29 0.0005
573 SKIN TOXICITY 3 0.0005
574 PEMPHIGOID 4 0.0005
575 TENDON PAIN 4 0.0005
576 CHRONIC KIDNEY DISEASE 40 0.0005
577 CONFUSIONAL STATE 85 0.0005
578 AORTIC ANEURYSM 4 0.0005
579 ACIDOSIS 4 0.0005
580 C-REACTIVE PROTEIN INCREASED 19 0.0005
581 GASTRIC HAEMORRHAGE 6 0.0005
582 BLOOD CREATINE PHOSPHOKINASE INCREASED 15 0.0005
583 EYELID OEDEMA 6 0.0005
584 POST PROCEDURAL HAEMORRHAGE 6 0.0005
585 STAPHYLOCOCCAL INFECTION 17 0.0005
586 TACHYPNOEA 7 0.0005
587 HYPOVOLAEMIA 3 0.0005
588 THERAPY NON-RESPONDER 23 0.0005
589 HEPATOMEGALY 5 0.0005
590 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 3 0.0005
591 PLEURISY 3 0.0005
592 DISORIENTATION 20 0.0005
593 DEMENTIA 14 0.0005
594 MELAENA 11 0.0005
595 BRAIN INJURY 5 0.0005
596 MIOSIS 4 0.0005
597 SENSORY LOSS 4 0.0005
598 INTERSTITIAL LUNG DISEASE 24 0.0005
599 BONE MARROW FAILURE 10 0.0005
600 CARDIOMEGALY 6 0.0005
601 LARYNGEAL OEDEMA 3 0.0005
602 INJECTION SITE EXTRAVASATION 6 0.0005
603 BLOOD ALKALINE PHOSPHATASE INCREASED 12 0.0005
604 PERITONITIS 10 0.0005
605 ILEUS 6 0.0005
606 INJECTION SITE HAEMATOMA 7 0.0005
607 EMBOLISM 4 0.0005
608 SWELLING OF EYELID 3 0.0005
609 HAEMODIALYSIS 4 0.0005
610 ABSCESS LIMB 2 0.0005
611 HAEMOPTYSIS 13 0.0005
612 INCOHERENT 3 0.0005
613 NEUTROPENIA 63 0.0005
614 HYPOGAMMAGLOBULINAEMIA 3 0.0005
615 NEUROTOXICITY 8 0.0005
616 ASPIRATION 5 0.0005
617 HEART RATE DECREASED 16 0.0005
618 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
619 ABDOMINAL ABSCESS 2 0.0005
620 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
621 ELECTROCARDIOGRAM QT PROLONGED 16 0.0004
622 METASTASES TO LYMPH NODES 3 0.0004
623 MYOCARDITIS 5 0.0004
624 HAEMATEMESIS 11 0.0004
625 BLOOD POTASSIUM INCREASED 7 0.0004
626 FORMICATION 3 0.0004
627 FLANK PAIN 4 0.0004
628 APPLICATION SITE REACTION 3 0.0004
629 INTENTIONAL OVERDOSE 27 0.0004
630 MUCOSAL INFLAMMATION 11 0.0004
631 LEUKOPENIA 21 0.0004
632 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
633 UPPER GASTROINTESTINAL HAEMORRHAGE 7 0.0004
634 HYPERCHOLESTEROLAEMIA 4 0.0004
635 PARKINSONISM 4 0.0004
636 CYTOPENIA 5 0.0004
637 BLOOD BILIRUBIN INCREASED 11 0.0004
638 BLINDNESS TRANSIENT 3 0.0004
639 GENERAL PHYSICAL HEALTH DETERIORATION 47 0.0004
640 HAEMOGLOBIN DECREASED 41 0.0004
641 BLOOD POTASSIUM DECREASED 12 0.0004
642 RECTAL HAEMORRHAGE 17 0.0004
643 PLATELET COUNT DECREASED 42 0.0004
644 TACHYCARDIA 35 0.0004
645 HYPERTHERMIA 3 0.0004
646 HYPOGLYCAEMIA 19 0.0004
647 LIPASE INCREASED 3 0.0004
648 RENAL FAILURE CHRONIC 3 0.0004
649 PHARYNGEAL OEDEMA 6 0.0004
650 MYDRIASIS 5 0.0004
651 EJECTION FRACTION DECREASED 6 0.0004
652 VENTRICULAR EXTRASYSTOLES 4 0.0004
653 PULMONARY HYPERTENSION 8 0.0004
654 PULMONARY HAEMORRHAGE 3 0.0004
655 LIVER DISORDER 17 0.0004
656 FOLLICULITIS 4 0.0004
657 HAEMATURIA 13 0.0004
658 MUSCLE DISORDER 3 0.0004
659 FAECES DISCOLOURED 8 0.0004
660 POST PROCEDURAL INFECTION 3 0.0004
661 GASTRIC ULCER 7 0.0004
662 SEROTONIN SYNDROME 7 0.0004
663 SPINAL COMPRESSION FRACTURE 3 0.0004
664 GENERALISED TONIC-CLONIC SEIZURE 6 0.0004
665 EOSINOPHIL COUNT INCREASED 3 0.0004
666 GASTROINTESTINAL HAEMORRHAGE 30 0.0004
667 RASH PAPULAR 8 0.0004
668 INFUSION SITE ERYTHEMA 3 0.0004
669 BLOOD CALCIUM DECREASED 4 0.0004
670 PYREXIA 123 0.0004
671 BRONCHOSPASM 5 0.0004
672 BLOOD MAGNESIUM DECREASED 3 0.0003
673 HYPERTHYROIDISM 5 0.0003
674 DYSARTHRIA 13 0.0003
675 FEEDING DISORDER 7 0.0003
676 HYPOTHYROIDISM 11 0.0003
677 ELECTROLYTE IMBALANCE 4 0.0003
678 SPINAL OSTEOARTHRITIS 3 0.0003
679 COVID-19 PNEUMONIA 4 0.0003
680 CARDIOMYOPATHY 5 0.0003
681 OXYGEN SATURATION DECREASED 19 0.0003
682 RENAL INJURY 10 0.0003
683 PRODUCT PRESCRIBING ERROR 8 0.0003
684 HAEMARTHROSIS 3 0.0003
685 HYPERLIPIDAEMIA 4 0.0003
686 GOUT 6 0.0003
687 FEBRILE NEUTROPENIA 22 0.0003
688 LEUKOCYTOSIS 6 0.0003
689 HALLUCINATION, VISUAL 7 0.0003
690 NO THERAPEUTIC RESPONSE 4 0.0003
691 BLOOD PRESSURE INCREASED 50 0.0003
692 AGITATION 24 0.0003
693 RESPIRATORY ARREST 9 0.0003
694 ANKLE FRACTURE 5 0.0003
695 PANCREATITIS 17 0.0003
696 HEPATIC ENCEPHALOPATHY 3 0.0003
697 PRODUCT DISPENSING ERROR 7 0.0003
698 NERVOUS SYSTEM DISORDER 10 0.0003
699 HEPATIC CIRRHOSIS 6 0.0003
700 DRUG-INDUCED LIVER INJURY 10 0.0003
701 CYANOSIS 5 0.0003
702 HAEMORRHAGE 33 0.0003
703 TRANSAMINASES INCREASED 7 0.0003
704 LIVER FUNCTION TEST ABNORMAL 9 0.0003
705 HEPATIC ENZYME INCREASED 21 0.0003
706 PLATELET COUNT INCREASED 4 0.0003
707 KNEE OPERATION 3 0.0003
708 OEDEMA PERIPHERAL 37 0.0003
709 HEPATIC FAILURE 9 0.0003
710 LETHARGY 17 0.0003
711 TOOTH ABSCESS 3 0.0003
712 GINGIVAL BLEEDING 4 0.0003
713 DIABETIC KETOACIDOSIS 7 0.0003
714 DIVERTICULITIS 8 0.0003
715 DERMATITIS 6 0.0003
716 LIVER INJURY 7 0.0003
717 DIABETES MELLITUS INADEQUATE CONTROL 5 0.0003
718 TOXICITY TO VARIOUS AGENTS 47 0.0003
719 ATRIAL FIBRILLATION 27 0.0003
720 FLUID OVERLOAD 4 0.0003
721 GASTROENTERITIS 4 0.0003
722 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 15 0.0003
723 RESTLESSNESS 10 0.0003
724 LOSS OF CONSCIOUSNESS 35 0.0003
725 CONDITION AGGRAVATED 83 0.0003
726 DRUG RESISTANCE 7 0.0003
727 FOOT DEFORMITY 3 0.0003
728 SYNCOPE 27 0.0003
729 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
730 HEPATIC STEATOSIS 5 0.0003
731 SEDATION 7 0.0003
732 INTESTINAL PERFORATION 3 0.0003
733 BLISTER 15 0.0003
734 DECREASED APPETITE 62 0.0003
735 CONTRAINDICATED PRODUCT ADMINISTERED 8 0.0003
736 MUSCULAR WEAKNESS 30 0.0003
737 BLOOD URINE PRESENT 5 0.0003
738 LUNG INFECTION 4 0.0003
739 HAEMORRHOIDS 5 0.0003
740 ANAPHYLACTIC REACTION 14 0.0003
741 SOMNOLENCE 51 0.0003
742 PNEUMONIA 82 0.0003
743 HAEMATOCRIT DECREASED 5 0.0003
744 CHOLECYSTITIS 3 0.0003
745 RASH ERYTHEMATOUS 12 0.0003
746 POLYNEUROPATHY 3 0.0003
747 WRIST FRACTURE 3 0.0003
748 OFF LABEL USE 216 0.0002
749 URINARY TRACT INFECTION 42 0.0002
750 VERTIGO 15 0.0002
751 NEUTROPHIL COUNT DECREASED 10 0.0002
752 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
753 ABNORMAL FAECES 2 0.0002
754 CHOLELITHIASIS 8 0.0002
755 SMALL INTESTINAL OBSTRUCTION 3 0.0002
756 SPINAL OPERATION 3 0.0002
757 FALL 81 0.0002
758 HYPERCALCAEMIA 3 0.0002
759 SEIZURE 28 0.0002
760 VISUAL ACUITY REDUCED 8 0.0002
761 PERICARDITIS 4 0.0002
762 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
763 HEMIPARESIS 4 0.0002
764 STOMATITIS 14 0.0002
765 DEEP VEIN THROMBOSIS 15 0.0002
766 NODULE 3 0.0002
767 VOMITING 108 0.0002
768 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
769 IMMUNE SYSTEM DISORDER 3 0.0002
770 CONVULSION 13 0.0002
771 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
772 EYE HAEMORRHAGE 3 0.0002
773 SWOLLEN TONGUE 7 0.0002
774 CARDIAC FAILURE CONGESTIVE 18 0.0002
775 THIRST 4 0.0002
776 GLOSSODYNIA 5 0.0002
777 CONSTIPATION 48 0.0002
778 BALANCE DISORDER 19 0.0002
779 MOVEMENT DISORDER 7 0.0002
780 CONJUNCTIVITIS 4 0.0002
781 PHOTOPHOBIA 4 0.0002
782 COLITIS 8 0.0002
783 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
784 DYSPHAGIA 20 0.0002
785 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
786 DISEASE RECURRENCE 10 0.0002
787 LIP SWELLING 7 0.0002
788 FEELING JITTERY 4 0.0002
789 TREATMENT FAILURE 17 0.0002
790 DRUG WITHDRAWAL SYNDROME NEONATAL 3 0.0002
791 EXTRAPYRAMIDAL DISORDER 5 0.0002
792 IMMUNODEFICIENCY 3 0.0002
793 PRESCRIBED UNDERDOSE 4 0.0002
794 PULMONARY EMBOLISM 19 0.0002
795 CHEST PAIN 37 0.0002
796 ABDOMINAL PAIN 46 0.0002
797 DEVICE FAILURE 3 0.0002
798 DYSKINESIA 8 0.0002
799 TINNITUS 9 0.0002
800 DEVICE RELATED INFECTION 3 0.0002
801 UPPER RESPIRATORY TRACT INFECTION 9 0.0002
802 INTENTIONAL PRODUCT USE ISSUE 17 0.0002
803 DIPLOPIA 5 0.0002
804 ASTHENIA 72 0.0002
805 DEAFNESS 5 0.0002
806 SPEECH DISORDER 10 0.0002
807 ARRHYTHMIA 9 0.0002
808 GASTRITIS 5 0.0002
809 ULCER 3 0.0002
810 PRODUCTIVE COUGH 9 0.0002
811 DEHYDRATION 25 0.0002
812 PALLOR 5 0.0002
813 PNEUMONITIS 5 0.0002
814 MULTIPLE FRACTURES 3 0.0002
815 FUNGAL INFECTION 6 0.0002
816 MEDICATION ERROR 10 0.0002
817 WOUND 5 0.0002
818 FACE OEDEMA 3 0.0002
819 BRONCHITIS 13 0.0002
820 ANGINA PECTORIS 5 0.0002
821 HYPERSOMNIA 5 0.0002
822 MUSCULOSKELETAL DISCOMFORT 3 0.0002
823 URINARY INCONTINENCE 5 0.0002
824 WITHDRAWAL SYNDROME 7 0.0002
825 GASTROENTERITIS VIRAL 3 0.0002
826 OSTEOARTHRITIS 7 0.0002
827 SUICIDE ATTEMPT 10 0.0002
828 NEURALGIA 4 0.0002
829 DIARRHOEA 106 0.0002
830 DYSURIA 6 0.0002
831 CHILLS 19 0.0002
832 GYNAECOMASTIA 5 0.0002
833 THROMBOSIS 13 0.0002
834 DYSPNOEA EXERTIONAL 6 0.0002
835 CELLULITIS 8 0.0002
836 ABDOMINAL PAIN LOWER 4 0.0002
837 FLUID RETENTION 8 0.0002
838 SLEEP APNOEA SYNDROME 3 0.0002
839 PRESCRIBED OVERDOSE 3 0.0002
840 SWELLING FACE 10 0.0002
841 ANHEDONIA 4 0.0002
842 ERYTHEMA 31 0.0002
843 DRUG INEFFECTIVE 198 0.0002
844 SKIN DISORDER 5 0.0001
845 COGNITIVE DISORDER 7 0.0001
846 DISTURBANCE IN ATTENTION 8 0.0001
847 RASH PRURITIC 8 0.0001
848 WHITE BLOOD CELL COUNT DECREASED 16 0.0001
849 LIMB INJURY 4 0.0001
850 GAIT DISTURBANCE 28 0.0001
851 RIB FRACTURE 3 0.0001
852 DYSPNOEA 82 0.0001
853 COMPLETED SUICIDE 12 0.0001
854 OVERDOSE 31 0.0001
855 INJURY 10 0.0001
856 CEREBROVASCULAR ACCIDENT 24 0.0001
857 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 10 0.0001
858 LIVER FUNCTION TEST INCREASED 3 0.0001
859 DYSSTASIA 4 0.0001
860 ACCIDENTAL OVERDOSE 5 0.0001
861 PAIN IN EXTREMITY 40 0.0001
862 DISEASE PROGRESSION 16 0.0001
863 TOOTH DISORDER 3 0.0001
864 PRODUCT USE ISSUE 25 0.0001
865 HALLUCINATION 10 0.0001
866 HYPERHIDROSIS 17 0.0001
867 PRODUCT AVAILABILITY ISSUE 3 0.0001
868 ANXIETY 37 0.0001
869 RENAL DISORDER 6 0.0001
870 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
871 COUGH 36 0.0001
872 SWELLING 12 0.0001
873 TREATMENT NONCOMPLIANCE 7 0.0001
874 HAEMATOCHEZIA 7 0.0001
875 ABSCESS 2 0.0001
876 BLOOD GLUCOSE DECREASED 6 0.0001
877 ABDOMINAL DISTENSION 13 0.0001
878 NIGHT SWEATS 4 0.0001
879 MENTAL IMPAIRMENT 3 0.0001
880 PRESYNCOPE 3 0.0001
881 MALAISE 53 0.0001
882 EPISTAXIS 9 0.0001
883 WHEEZING 7 0.0001
884 HYPOPHAGIA 3 0.0001
885 PRODUCT USE IN UNAPPROVED INDICATION 29 0.0001
886 ERECTILE DYSFUNCTION 3 0.0001
887 INFLAMMATION 6 0.0001
888 SKIN ULCER 3 0.0001
889 NO ADVERSE EVENT 21 0.0001
890 NIGHTMARE 4 0.0001
891 RESPIRATORY TRACT INFECTION 3 0.0001
892 NEOPLASM PROGRESSION 4 0.0001
893 ECZEMA 6 0.0001
894 MYOCARDIAL INFARCTION 20 0.0001
895 PRURITUS 43 0.0001
896 FEAR 3 0.0001
897 PROCEDURAL PAIN 3 0.0001
898 HOT FLUSH 8 0.0001
899 VISUAL IMPAIRMENT 13 0.0001
900 HYPERSENSITIVITY 19 0.0001
901 PARAESTHESIA 16 0.0001
902 DYSPEPSIA 10 0.0001
903 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
904 ABNORMAL BEHAVIOUR 4 0.0001
905 HEART RATE INCREASED 10 0.0001
906 HEADACHE 63 0.0001
907 AGGRESSION 5 0.0001
908 ABORTION SPONTANEOUS 4 0.0001
909 IRRITABILITY 6 0.0001
910 CORONARY ARTERY DISEASE 3 0.0001
911 BACK PAIN 23 0.0001
912 DRY MOUTH 8 0.0001
913 DIZZINESS 49 0.0001
914 MALIGNANT NEOPLASM PROGRESSION 10 0.0001
915 FEMUR FRACTURE 3 0.0001
916 DEPRESSION 22 0.0001
917 RASH 41 0.0001
918 HIP FRACTURE 3 0.0001
919 DIABETES MELLITUS 7 0.0001
920 BLOOD GLUCOSE INCREASED 17 0.0001
921 GAIT INABILITY 3 0.0001
922 COLITIS ULCERATIVE 4 0.0001
923 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
924 GASTROINTESTINAL DISORDER 8 0.0001
925 CHEST DISCOMFORT 9 0.0001
926 VISION BLURRED 12 0.0001
927 MEMORY IMPAIRMENT 12 0.0001
928 NAUSEA 68 0.0001
929 PALPITATIONS 10 0.0001
930 BONE PAIN 5 0.0001
931 NASAL CONGESTION 5 0.0001
932 FEELING HOT 5 0.0001
933 INTESTINAL OBSTRUCTION 3 0.0001
934 INCORRECT DOSE ADMINISTERED 18 0.0001
935 SINUSITIS 8 0.0001
936 INFECTION 11 0.0001
937 CONTUSION 7 0.0001
938 WEIGHT INCREASED 16 0.0001
939 ASTHMA 8 0.0001
940 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
941 ARTHRALGIA 29 0.0001
942 DYSPHONIA 4 0.0001
943 DRUG WITHDRAWAL SYNDROME 6 0.0001
944 DEATH 58 0.0001
945 TREMOR 11 0.0001
946 PRODUCT QUALITY ISSUE 9 0.0001
947 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
948 URTICARIA 11 0.0001
949 FATIGUE 51 0.0001
950 PERIPHERAL SWELLING 10 0.0001
951 BLOOD CHOLESTEROL INCREASED 3 0.0001
952 CARDIAC DISORDER 6 0.0001
953 PAIN 39 0.0001
954 OCULAR HYPERAEMIA 3 0.0001
955 NEUROPATHY PERIPHERAL 6 0.0001
956 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
957 AMNESIA 4 0.0001
958 HYPOAESTHESIA 9 0.0001
959 INSOMNIA 16 0.0001
960 FLUSHING 6 0.0001
961 INTENTIONAL PRODUCT MISUSE 5 0.0001
962 COVID-19 10 0.0001
963 SLEEP DISORDER 4 0.0001
964 ADVERSE DRUG REACTION 5 0.0001
965 UNDERDOSE 4 0.0001
966 DYSGEUSIA 4 0.0001
967 WEIGHT DECREASED 15 0.0001
968 NECK PAIN 3 0.0001
969 MIGRAINE 5 0.0001
970 PRODUCT SUBSTITUTION ISSUE 3 0.0001
971 ABDOMINAL PAIN UPPER 10 0.0000
972 SKIN EXFOLIATION 4 0.0000
973 MYALGIA 8 0.0000
974 MUSCULOSKELETAL STIFFNESS 4 0.0000
975 ADVERSE EVENT 4 0.0000
976 MOBILITY DECREASED 3 0.0000
977 ABDOMINAL DISCOMFORT 7 0.0000
978 DRUG INTOLERANCE 4 0.0000
979 EMOTIONAL DISTRESS 5 0.0000
980 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 7 0.0000
981 MUSCLE SPASMS 7 0.0000
982 DRY SKIN 5 0.0000
983 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
984 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
985 NASOPHARYNGITIS 6 0.0000
986 INJECTION SITE ERYTHEMA 4 0.0000
987 FEELING ABNORMAL 7 0.0000
988 ACNE 2 0.0000
989 ALOPECIA 5 0.0000
990 DRUG DEPENDENCE 4 0.0000
991 DRUG DOSE OMISSION 4 0.0000
992 PSORIASIS 3 0.0000
993 INJECTION SITE PAIN 6 0.0000
994 HOSPITALISATION 3 0.0000